In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.
about
Aptamers: A Feasible Technology in Cancer ImmunotherapyEpigenetics in myeloid derived suppressor cells: a sheathed sword towards cancersiRNA and RNAi optimizationTargeting the tumor microenvironment: JAK-STAT3 signalingThe Yin and Yang of Toll-like receptors in cancerNanomedicine therapeutic approaches to overcome cancer drug resistanceAntitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in MiceAptamer-Mediated Targeted Delivery of Therapeutics: An UpdateAptamers: A New Technological Platform in Cancer ImmunotherapySignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyKnocking down disease: a progress report on siRNA therapeuticsCurrent prospects for RNA interference-based therapiesProgress toward in vivo use of siRNAs-IISilencing disease genes in the laboratory and the clinicRNA Interference and Cancer TherapySTATs in cancer inflammation and immunity: a leading role for STAT3S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.Push and release: TLR9 activation plus STAT3 blockade for systemic antitumor immunity.Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBMAptamer-targeted cell-specific RNA interferenceRegulation and function of signal transducer and activator of transcription 3.Biocoder: A programming language for standardizing and automating biology protocols.CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticlesRational design of immunostimulatory siRNAs.Eupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling.HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activityApplications of proteomic technologies for understanding the premature proteolysis of CFTR.Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway.TLR9 is critical for glioma stem cell maintenance and targeting.Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoThe dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy.Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3.Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease
P2860
Q26740303-70B9078F-62F8-4C19-9BF5-B8F9448B0634Q26741623-999B2323-36F7-4BF4-96B2-6AD969AFBFBEQ26769738-4245D1AE-72A8-4F44-B723-91858E4BA06CQ26825658-3419107E-5EA3-46DE-A5F7-F50B33122098Q26851526-C68A3858-51B6-4A55-A273-DAC1D818C723Q27011692-0747C9D7-F793-4B29-BFB2-F3F39F4301AFQ27318732-CBDCC188-A6C8-432E-919D-E4F00466AA8AQ28066827-4475AECE-28BB-47D5-9E5E-C18C18E9197AQ28068981-6E18BF86-277F-4E38-BCF6-8F8E4804969DQ28080262-55A5E165-1440-46D0-81D1-4E7330A3F6ABQ28082939-D2A06163-9680-417F-B076-C9C8262D22D1Q28235733-3D93657C-A7EC-4062-A653-18A81A639993Q28255877-17E6E1FC-DCDA-4E31-8DC9-E53FB19DA270Q29039090-D6971401-F2FC-4CA7-87E9-11CD28FC9E30Q29392204-6D9E0409-AB11-47C0-BE51-D52FB6C87750Q29547203-52908AA1-2140-4A86-9FDD-F4CF85DA8DE8Q30514214-868B58A2-F51C-4B0E-8FAF-BB3396512048Q31085777-D861643E-B819-419C-8D1B-FFA5C6D73A31Q33553545-0FE0C39B-2B26-4488-8A71-E1BEFB330F3CQ33578030-23B16C0C-89D0-4485-9CB5-9008B91F151EQ33717239-843EDDE1-F7E2-4C73-AC62-1B7BDFDAFB1CQ33728856-DF676D9C-B785-409E-8CBD-71B47598F111Q33741156-5B3B74CA-D838-4C9E-97FF-437FB33B932EQ33808334-271E3025-C1C4-4ED6-A95E-59237B363AD2Q33811442-555EAC29-3129-467A-BF16-E6A3324E6237Q33822185-FEE2192B-0AD7-42E0-BB76-A622CD0738F9Q33827192-EC331198-8264-44E7-9507-2A004D22BC69Q33906033-55B461FA-6F5C-431D-9ED5-0891C9601CABQ33921803-993C23AB-B960-4505-A446-2B457EE98C48Q33986439-E50EDB8B-F6D5-4E1B-84F3-C3EB1F19E64AQ34076025-01B8C663-1A2E-47F9-ADD3-EE5D23EF5D52Q34154752-7E3632D7-2484-4C44-8C66-095D2D1B27D3Q34204722-9D1594B7-9E47-4C98-A929-05C14D87A972Q34313026-1975D783-0D82-4702-9E46-129E406F2D47Q34320769-025BDB75-C3F6-44EA-B20A-AF938DCFAE94Q34373036-89C21BB3-6274-4C13-8684-4D35404978C6Q34419534-1E01135E-6A36-417C-A1AD-C99308D4EBC4Q34473451-58440B25-2AFD-44A6-946E-04B8A07F49A3Q34552079-280086BA-B7F5-40EB-AB0A-FE95CE3D8A8BQ34553476-4E9A9100-F434-4E91-8478-6F868C8016AC
P2860
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@en
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@nl
type
label
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@en
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@nl
prefLabel
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@en
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@nl
P2093
P2860
P356
P1433
P1476
In vivo delivery of siRNA to i ...... es antitumor immune responses.
@en
P2093
Andreas Herrmann
Andrew Raubitschek
Anna Scuto
Chunmei Yang
Claudia Kowolik
Drew M Pardoll
Harris S Soifer
Heehyoung Lee
Jiehui Deng
P2860
P2888
P304
P356
10.1038/NBT.1564
P577
2009-09-13T00:00:00Z